"The May 19, 2009 JAMA article notes that Correll's study "adds to a growing body of evidence suggesting that children and adolescents are more vulnerable to antipsychotic adverse events, including not only weight gain and lipid abnormalities, but also sedation, extrapyramidal adverse effects, prolactin elevation, and withdrawal.""